Back to resultsCan Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?
Primary Purpose
Chronic Obstructive Pulmonary Disease
Status
Completed
Phase
Phase 4
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Macrolid, Theophylline, Inhaler Corticosteroids
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, Macrolid, reversibility, Theophylline, Corticosteroids, symptoms PFT
Eligibility Criteria
Inclusion Criteria:
- current or past smoker COPD
Exclusion Criteria:
- history of significant occupational or other environmental exposures or a connective tissue disease
Sites / Locations
- Research Center of Chemical Injuries, Baqiyatallah Medical Sciences University, Mollasadra St,
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Macrolid, Theophylline, Corticosteroids
Arm Description
Approved drug in this setting
Outcomes
Primary Outcome Measures
15% increasing in forced expiratory volume in 1 second
Secondary Outcome Measures
Full Information
NCT ID
NCT01010178
First Posted
November 6, 2009
Last Updated
November 6, 2009
Sponsor
Baqiyatallah Medical Sciences University
1. Study Identification
Unique Protocol Identification Number
NCT01010178
Brief Title
Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?
Official Title
Combination of Approved Drug in COPD
Study Type
Interventional
2. Study Status
Record Verification Date
November 2009
Overall Recruitment Status
Completed
Study Start Date
February 2008 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
July 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Baqiyatallah Medical Sciences University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Critical combination of various approved drugs in management for patients suffering with COPD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
COPD, Macrolid, reversibility, Theophylline, Corticosteroids, symptoms PFT
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
N/A
Enrollment
64 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Macrolid, Theophylline, Corticosteroids
Arm Type
Experimental
Arm Description
Approved drug in this setting
Intervention Type
Drug
Intervention Name(s)
Macrolid, Theophylline, Inhaler Corticosteroids
Intervention Description
we have no permission to include them in detail because of privacy policy of mentioned journal for publication
Primary Outcome Measure Information:
Title
15% increasing in forced expiratory volume in 1 second
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
86 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
current or past smoker COPD
Exclusion Criteria:
history of significant occupational or other environmental exposures or a connective tissue disease
Facility Information:
Facility Name
Research Center of Chemical Injuries, Baqiyatallah Medical Sciences University, Mollasadra St,
City
Tehran
ZIP/Postal Code
19945-546
Country
Iran, Islamic Republic of
12. IPD Sharing Statement
Learn more about this trial
Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?
We'll reach out to this number within 24 hrs